Bharat Biotech to donate 2 lakh Covaxin doses to Vietnam MD Bureau17 Dec 2021 12:36 PM ISTHyderabad: Bharat Biotech announced on Thursday that it will donate two lakh doses of its Covid-19 vaccine Covaxin to Vietnam. The announcement was...
Can Covaxin protect against Omicron? Bharat Biotech to examine Ruchika Sharma1 Dec 2021 12:29 PM ISTNew Delhi: India's Bharat Biotech said on Tuesday it was studying if its Covaxin shot would work against variants of coronavirus such as Omicron,...
Bharat Biotech resumes Covaxin exports Ruchika Sharma29 Nov 2021 2:59 PM ISTBengaluru: Indian vaccine maker Bharat Biotech said on Monday it has resumed export of its COVID-19 shot, Covaxin, and has executed long-pending...
USFDA issues clinical hold on Covaxin new drug application: Ocugen Ruchika Sharma29 Nov 2021 11:30 AM ISTMalvern: Ocugen, Inc. has recently announced that the U.S. Food and Drug Administration (FDA) has issued a clinical hold on the Company's...
Decline in Covaxin effectiveness to 50 percent during Delta-driven COVID surge not bad: Experts Medical Dialogues Bureau28 Nov 2021 11:00 AM ISTNew Delhi: The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8% to 50% during a Delta-driven case surge in...
Covaxin 50 percent effective against symptomatic Covid-19: Lancet study Medical Dialogues Bureau25 Nov 2021 9:15 AM ISTThe latest study assessed 2,714 hospital workers at the All India Institute of Medical Sciences (AIIMS) in Delhi, from April 15May 15, who were...
Covaxin true example of public-private partnership: ICMR Chief MD Bureau24 Nov 2021 12:17 PM ISTNew Delhi: The development of India's indigenous vaccine -- Covaxin, is a true example of public-private partnership marked with trust and and...
Bharat Biotech says developing Covaxin was big challenge MD Bureau19 Nov 2021 1:00 PM ISTBengaluru: Bharat Biotech Director, V. Krishna Mohan, has said developing the Covaxin in "just 10 months" was an enormous challenge. Addressing...
Phase 3 data shows Covaxin 77.8 percent effective against COVID: Lancet Roshni Dhar16 Nov 2021 4:05 PM ISTBharat Biotech has recently announced that the safety and efficacy analysis data from Phase III clinical trials of COVAXIN is peer reviewed and...
Covaxin has cellular immune memory to COVID for at least 6 months: NII Ruchika Sharma16 Nov 2021 1:21 PM ISTNew Delhi: Bharat Biotech's Covaxin has immunological memory to Covid and its variants of concern for at least up to six months, National...
Health Bulletin 13/November/2021 Roshni Dhar13 Nov 2021 6:00 PM ISTHere are Top Health stories of the dayBreach of duty in providing medical advice: Consumer Court Directs Nephrologist, Hospital to pay Rs 3 lakh...
Phase 3 data shows Covaxin 77.8 percent effective against Covid-19, says Lancet Ruchika Sharma13 Nov 2021 11:46 AM ISTHyderabad: Bharat Biotech has recently announced that the safety and efficacy analysis data from Phase III clinical trials of COVAXIN is peer...
